↧
ZTI Biosciences Engages EF Hutton as Strategic and Financial Advisor
DAEJEON, South Korea ZTI Biosciences Co., Ltd. (“ZTI Biosciences” or “ZTI”), a radiopharmaceutical developer for cancer therapy based on nanomaterial technology, today announced that it has entered...
View Article